Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Debt Ratio (2016 - 2025)

IGC Pharma (IGC) has disclosed Debt Ratio for 15 consecutive years, with 0.01 as the latest value for Q3 2025.

  • On a quarterly basis, Debt Ratio rose 4.06% to 0.01 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.01, a 4.06% increase, with the full-year FY2025 number at 0.02, up 10.73% from a year prior.
  • Debt Ratio was 0.01 for Q3 2025 at IGC Pharma, down from 0.02 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.02 in Q2 2025 to a low of 0.0 in Q2 2021.
  • A 5-year average of 0.01 and a median of 0.01 in 2023 define the central range for Debt Ratio.
  • Biggest YoY gain for Debt Ratio was 837.39% in 2021; the steepest drop was 80.44% in 2021.
  • IGC Pharma's Debt Ratio stood at 0.0 in 2021, then skyrocketed by 48.52% to 0.01 in 2022, then surged by 74.46% to 0.01 in 2023, then increased by 20.43% to 0.01 in 2024, then fell by 8.22% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Debt Ratio are 0.01 (Q3 2025), 0.02 (Q2 2025), and 0.02 (Q1 2025).